View Single Post
Old 11-03-2017, 10:30 AM   Nav to Top 
Senior Trader
Biohero's Avatar
Join Date: Jan 2012
Location: Frankfurt
Posts: 227
Favorites: Aapl celg onxx
Rep Power: 102
Reputation: 36
Biohero is on a distinguished road

Great time to load up nowafter they resubmit the NDA for Rizaport early this week .GL

RedHill Biopharma and IntelGenx Submit New Drug Application to FDA for RIZAPORT® for Migraines..November 1, 2017

Market Cap : US$48 Million / Cash US$8.2 million /very low burn-rate of ~$700K a Quarter =Cash untill 2020+ EXCLUDING payments from new partnerships ,profitability expected quickly with approval for Rizaport and Tadalafil both approval expected in 2018, if everything goes well then this stock could run to $10 even then it wouldnt be expensive .

Intelgenx (IGXT)

Markt-Cap $48 Million
Cash 8.1 Million
Price: $0.73

FDA Decision for Rizaport(Migraine) in Q2/2018 (Peak Sales $60-80 Million)

NDA submission for Tadalafil (erectile dysfunction) this Quarter >> FDA approval in 2H 2018 (Peak Sales $150++ Million)

Start Phase 2a for Montulukast (Alzheimer disease) this Quarter >> Phase 2a Results in 1H/2018 (Potential BLOCKBUSTER Drug)

Opioid dependence drug partnered with Par Pharma >> FDA approval depends on patent ruling (Peak Sales $100++ Million) 30-Month Stay already expired

MEGA Pipeline

Biohero is offline   Rate this post Yes | No Reply With Quote